Wilms tumor genetics

American Journal of Medical Genetics

Volumn 79, Issue 4, 1998, Pages 260-267

  Huff, Vicki ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer genetics; Familial cancer predisposition; Wilms tumor; WT1

Indexed keywords

CANCER SUSCEPTIBILITY; CHILD; CHILDHOOD CANCER; CHROMOSOME 11P; CONFERENCE PAPER; FAMILY HISTORY; GENE LOCUS; GENETIC PREDISPOSITION; HUMAN; MAJOR CLINICAL STUDY; NEPHROBLASTOMA; PRIORITY JOURNAL;

HUMANS; KIDNEY NEOPLASMS; WILMS TUMOR;

EID: 0032476037     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19981002)79:4<260::AID-AJMG6>3.0.CO;2-Q     Document Type: Conference Paper

References (86)

1. Altura RA, Valentine M, Li H, Boyett JM, Shearer P, Grundy P, Shapiro DN, Look AT (1996): Identification of novel regions of deletion in familial Wilms' tumor by comparative genome hybridization. Cancer Res 56:3837-3841.
2. Beckwith JB (1969): Macroglossia, Omphalocele, Adrenal Cytomegaly, Gigantism, and Hyperplastic Visceromegaly. In Bergsma D (ed): "The Clinical Delineation of Birth Defects, Part II." New York: National Foundation-March of Dimes, pp. 188-190.
3. Breslow NE, Olshan A, Beckwith JB, Green DM (1993): Epidemiology of Wilms tumor. Med Pediatr Oncology 21:172-181.
4. Breslow NE, Olson J, Moksness J, Beckwith JB, Grundy P (1996): Familial Wilms' tumor: a descriptive study. Med Ped Oncol 27:398-403.
5. Brannan CI, Dees EC, Ingram RS, Tilghman SM (1990): The product of the H19 gene may function as an RNA. Molec Cell Biol 10:28-36.
6. Brown WT, Puranik SR, Altman DH, Hardin HC (1972): Wilms' tumor in three successive generations. Surgery 72:756-761.
7. Brunkow ME, Tilghman SM (1991): Ectopic expression of the H19 gene in mice causes prenatal lethality. Genes Devel 5:1092-1101.
8. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, Housman DE (1990): Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60:509-520.
9. Chao L-Y, Huff V, Tomlinson G, Riccardi VM, Strong LG, Saunders GF (1993): Genetic mosaicism in normal tissues of Wilms' tumour patients. Nature Genet 3:127-131.
10. Chung W-Y, Yuan L, Feng L, Hensle T, Tycko B (1996): Chromosome 11p15.5 regional imprinting: comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors. Human Mol Genet 5:1101-1108.
11. Cui H, Hedborg F, He L, Nordenskjold A, Sandstedt B, Pfeifer-Ohlsson S, Ohlsson R (1997): Inactivation of H19, an imprinted and putative tumor repressor gene, is a preneoplastic event during Wilms' tumorigenesis. Cancer Res 57:4469-4473.
12. Douglass EC, Willimas JA, Green AA, Look AT (1985): Abnormalities of chromosomes 1 and 11 in Wilms' tumor. Cancer Genet Cytogenet 14: 331-338.
13. Drash A, Sherman F, Hartmann WH, Blizzard RM (1970): A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal disease. J Pediatr 76:585-593.
14. Drummond IA, Madden SL, Rohwer-Nutter P, Bell GI, Sukhatme VP, Rauscher FJ III (1992): Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science 257:674-678.
15. Gessler M, Proustka A, Cavenee W, Neve RL, Orkin SH, Bruns GAP (1990): Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 343:774-778.
16. Gessler M, Konig A, Bruns GAP (1992): The genomic organization and expression of the WT1 gene. Genomics 12:807-813.
17. Gessler M, Konig A, Arden K, Grundy P, Orkin S, Sallan S, Peters C, Ruyle S, Mandell J, Li F, Cavenee W, Bruns F (1994): Infrequent mutation of the WT1 gene in 77 Wilms' tumors. Human Mutat 3:212-222.
18. Grundy P, Koufos A, Morgan K, Li FP, Meadows AT, Cavenee WK (1988): Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11. Nature 336:374-376.
19. Gunning KB, Cohn SL, Tomlinson GE, Strong LC, Huff V (1996): Analysis of possible abnormal WT1 RNA processing in primary Wilms tumors. Oncogene 13:1179-1185.
20. Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE (1991): Alternative splicing and genomic structure of the Wilms tumor gene, WT1. Proc Natl Acad Sci USA 88:9618-9622.
21. Haber DA, Park S, Maheswaran S, Englert C, Re FF, Hazen-Martin DJ, Sens DA, Garvin AJ (1993): WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant. Science 262: 2057-2059.
22. Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B (1993): Tumour-suppressor activity of H19 gene. Nature 365:764-767.
23. Hartley AL, Birch JM, Tricker K, Wallace SA, Kelsey AM, Harris M, Morris Jones PH (1993): Wilms' tumor in the Li-Fraumeni family syndrome. Cancer Genet Cytogenet 67:133-135.
24. KIP2 and its reduced expression in Wilms' tumors. Human Molecular Genet 5: 783-788.
25. KIP2 is mutated in Beckwith-Wiedemann syndrome. Nature 14:171-173.
26. Henry I, Bonaïti-Pellié C, Chehensse V, Beldjord C, Schwartz C, Utermann G, Junien C (1991): Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature 351:665-667.
27. Hoovers JMN, Kalikin LM, Johnson LA, Alders M, Redeker B, Law DJ, Bliek J, Steenman M, Benedict M, Wiegant J, Lengauer C, Taillon-Miller P, Schlessinger D, Edwards MC, Elledge SJ, Ivens A, Westerveld A, Little P, Mannenes M, Feinberg AP (1995): Multiple genetic loci within 11p15 defined by Beckwith-Wiedem ann syndrome rearrangement breakpoints and subchromosomal transferable fragments. Proc Natl Acad Sci USA 92:12456-12460.
28. Huff V, Compton DA, Chao L-Y, Strong LC, Geiser CF, Saunders GF (1988): Lack of linkage of familial Wilms' tumour to chromosomal band 11p13. Nature 336:377-378.
29. Huff V, Villalba F, Riccardi VM, Strong LC, Saunders GF (1991a): Alteration of the WT1 gene in patients with Wilms' tumor and genitourinary anomalies. Amer J Hum Genet 49:44.
30. Huff V, Miwa H, Haber DA, Call KM, Housman D, Strong LC, Saunders GF (1991b): Evidence for WT1 as a Wilms tumor (WT) gene: Intragenic germinal deletion in bilateral WT. Am J Hum Genet 48:997-1003.
31. Huff V, Reeve AE, Leppert M, Strong LC, Douglass EC, Geiser DF, Li FP, Meadows A, Callen DF, Lenoir G, Saunders GF (1992): Nonlinkage of 16q markers to familial predisposition to Wilms' tumor. Cancer Res 52:6117-6120.
32. Huff V, Jaffe N, Saunders GF, Strong LC, Villalba F, Ruteshouser EC (1995): WT1 exon 1 deletion/insertion mutations in Wilms tumor patients associated with di- and trinucleotide repeats and deletion hotspot consensus sequences. Amer J Hum Genet 56:84-90.
33. Huff V, Amos CI, Douglass ED, Fisher R, Geiser CF, Krill CE, Li FP, Strong LC, McDonald JM (1997): Evidence for genetic heterogeneity in familial Wilms tumor. Cancer Res 57:1859-1862.
34. Hughes-Benzie RM, Pilia F, Xuan JY, Hunter AGW, Chen E, Golabi M, Hurst JA, Kobori J, Marymee K, Pagon RA, Punnett HH, Schelley S, Tolmie JL, Wohlferd MM, Grossman T, Schlessinger D, MacKenzie AE (1996): Simpson-Golabi-Behmel syndrome: genotypc/phenotype analysis of 18 affected males from 7 unrelated families. Amer J Med Genet 66:227-234.
35. Kakinuma A, Morimoto I, Nakano Y, Fujimoto R, Ishida O, Okada Y, Inokuchi N, Fujihira T, Eto S (1994): Familial primary hyperparathyroidism complicated with Wilms' tumor. Intern Med 33:123-126.
36. Kaneko Y, Homma C, Maseki N, Sakurai M, Hata J (1991): Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors. Cancer Res 51:5937-5942.
37. Knudson AG, Strong LC (1972): Mutation and cancer: a model for Wilms' tumor of the kidney. J Natl Cancer Instit 48:313-324.
38. Kondo K, Chilcote RR, Maurer HS, Rowley JD (1984): Chromosome abnormalities in tumor cells from patients with sporadic Wilms' tumor. Cancer Res 44:5376-5381.
39. Koufos A, Hansen MF, Lampkin BC, Workman ML, Copeland NG, Jenkins NA, Cavenee WK (1984): Loss of alleles at loci on human chromosome II during genesis of Wilms' tumour. Nature 309:170-172.
40. Koufos A, Grundy P, Morgan K, Aleck KA, Hadro T, Lampkin BC, Kalbakji A, Cavenee WK (1989): Familial Wiedemann-Beckwith syndrome and a second Wilms' tumor locus both map to 11p15.5. Am J Hum Genet 44:711-719.
41. Leibovitch MP, Nguyen VC, Gross MS, Solhonne B, Leibovitch SA, Bernheim A (1991): The human ASM (adult skeletal muscle) gene: expression and chromosomal assignment to 11p15. Biochem Biophys Res Commun 180:1241-1250.
42. Leighton PA, Ingram RS, Eggenschwiler J, Efstratiadia A, Tilghman SM (1995): Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature 375:34-39.
43. Li X, Adam G, Cui H, Sandstedt B, Ohlsson R, Ekstrom TJ (1995): Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting. Oncogene 11:221-229.
44. Little MH, Dunn R, Byrne JA, Seawright A, Smith PJ, Pritchard-Jones K, van Heyningen V, Hastie ND (1992): Equivalent expression of paternally and maternally inherited WT1 alleles in normal fetal tissue and Wilms' tumours. Oncogene 7:635-641.
45. Madden SL, Cook DM, Morris JF, Gashier A, Sukhatme VP, Rauscher FJ III (1991): Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science 253:1550-1553.
46. Mannens M, Devilee P, Biliek J, Mandjes I, de Kraker J, Heyting C, Slater RM, Westerveld A (1990): Loss of heterozygosity in Wilms' tumors, studied for six putative tumor suppressor regions, is limited to chromosome 11. Cancer Res 50:3279-3283.
47. Matsunaga E (1981): Genetics of Wilms' tumor. Hum Genet 57:231-246.
48. CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Devel 9:650-662.
49. KIP2, on chromosome 11p15. Proc Natl Acad Sci USA 93:3026-3030.
50. Maw M, Grundy PE, Millow LJ, Eccels MR, Dunn RS, Smith PJ, Feinberg AP, Law DJ, Paterson MC, Telzerow PE, Callen DF, Thompson AD, Richards RI, Reeve AE (1992): A third Wilms' tumor locus on chromosome 16q. Cancer Res 52:3094-3098.
51. Miwa H, Tomlinson GE, Timmons CS, Huff V, Cohn SL, Strong LC, Saunders GF (1992): RNA expression of the WT1 gene in Wilms' tumors in relation to histopathology. J Natl Cancer Inst 84:181-187.
52. Miozzo M, Perotti D, Minoletti F, Mondini P, Pilotti S, Luksch R, Fassati-Bellani F, Pierotti MA, Sozzi F, Radice P (1996): Mapping of a putative tumor suppressor locus to proximal 7p in Wilms tumors. Genomics 37:310-315.
53. Moulton T, Crenshaw T, Hao Y, Moosikasuwan J, Lin N, Dembitzer F, Hensle T, Wiess L, McMorrow L, Loew T, Kraus W, Gerald W, Tycko B (1994): Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nature Genet 7:440-447.
54. Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA, Smith PJ, Reeve AE (1993): Relaxation of insulin-like growth factor II gene impriting implicated in Wilms' tumor. Nature 362:749-751.
55. Oison JM, Hamlton A, Breslow NE (1995): Non-lip constitutional chromosome abnormalities in Wilms' tumor patients. Medical Fed Oncol 24:305-309.
56. Orkin SH, Goldman DS, Sallan SE (1984): Development of homozygosity of chromosome lip markers in Wilms' tumour. Nature 309:172-174.
57. de Pagter-Holthuizen P, Jansen M, van der Kammen RA, van Schaik FMA, Sussenbach JS (1988): Differential expression of the human insulin-like growth factor II gene. Characterization of the IGF-II mRNAs and an mRNA encoding a putative IGF-II-associated protein. Biochim Biophys Acta 950:282-295.
58. Pelletier J, Bruening W, Kashtan CD, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, Fine RN, Silverman BL, Haber DA, Housman DE (1991): Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67:437-447.
59. Ping AJ, Reeve AE, Law DJ, Young MR, Boehnke M, Feinberg AP (1989): Genetic linkage of Beckwith-Wiedemann syndrome to 11p15. Am J Hum Genet 44:720-723.
60. Rachmilewitz J, Goshen R, Ariel I, Schneider T, de Groot N, Hochberg A (1992): Parental imprinting of the human H19 gene. FEBS Letters 309:25-28.
61. Rahman N, Arbour L, Tonin P, Renshaw J, Pelletier J, Baruchel S, Pritchard-Jones K, Stratton MR, Narod SA (1996): Evidence for a familial Wilms' tumor gene (FWT1) on chromosome 17q12-q21. Nat Genet 13:461-462.
62. Rainier S, Johnsone L, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP (1993): Relaxation of imprinted genes in human cancer. Nature 362:747-749.
63. Rauscher FJ III, Morris JF, Tournay OE, Cook DM, Curran T (1990): Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science 250:1259-1262.
64. Reeve AE, Housiaux PJ, Gardner RJM, Chewings WE, Grindley RM, Millow LJ (1984): Loss oa a Harvey ras allele in sporadic Wilms' tumour. Nature 309:174-176.
65. Riccardi VM, Sujansky E, Smith AC, Francke U (1978): Chromosomal imbalance in the aniridia-Wilms' tumor association: lip interstitial deletion. Pediatrics 61:604-610.
66. Schimmenti LA, Cich JA, Gorlin RJ, Berry SA (1993): Autosomal dominant inheritance of Wilms' tumor and brachial cleft anomalies. A new syndrome. Amer J Hum Genet 53:503.
67. Schroeder WT, Chao L-Y, Dao DD, Strong LC, Pathak S, Riccardi V, Lewis WH, Saunders GF (1987): Nonrandom loss of maternal chromosome 11 alleles in Wilms tumors. Am J Hum Genet 40:413-420.
68. Sharma PM, Bowman M, Madden SL, Rauscher FJ III, Sukumar S (1994): RNA editing in the Wilms' tumor susceptibility gene, WT1. Genes Devel 8:720-731.
69. Slater RM (1986): The cytogenetics of Wilms' tumor. Cancer Genet Cytogenet 19:37-41.
70. Sous V, Pritchard J, Cowell JK (1988): Cytogenetic changes in Wilms' tumors. Cancer Genet Cytogenet 34:223-234.
71. Sotelo-Avila C, Gonzalez-Crussi F, Fowley JW (1980): Complete and incomplete forms of Beckwith-Wiedemann syndrome: their oncogenic potential. J Pediatr 96:47-50.
72. Stay EJ, Vawter G (1977): The relationship between nephroblastoma and neurofibromatosis (Von recklinghausen's disease). Cancer 39:2550-2555.
73. Steenman M, Redeker B, de Meulemeester M, Wiesmeijer K, Voute PA, Westerveld A, Slater R, Mannens M (1997): Comparative genomic hybridization analysis of Wilms tumors. Cytogenet Cell Genet 77:296-303.
74. Szabo J, Heath B, Hill VM, Jackson CE, Zarbo RJ, Mallette LE, Chew SL, Besser GM, Thakker RV, Huff V, Leppert MF, Health H (1995): The hereditary hyperparathyroidism-jaw tumor syndrome: a new endocrine tumor gene mapping to chromosome 1q21-q31. Amer J Hum Genet 56:944-950.
75. KIP2 in wilms' tumor. Cancer Res 56:5723-5727.
76. Ton CCT, Huff V, Call KM, Cohn S, Strong LC, Housman DE, Saunders GF (1991): Smallest region of overlap in Wilms' tumor deletions uniquely implicates an 11p13 zinc finger gene as the disease locus. Genomics 10:293-297.
77. Turleau C, de Grouchy J, Chavin-Colin F, Martelli H, Voyer M, Charlas R (1984): Trisomy 11p15 and Beckwith-Wiedemann syndrome. A report of two cases. Hum Genet 67:219-221.
78. Uyeno S, Acki Y, Nata M, Sagisaka K, Kayama T, Yoshimoto T, Ono T (1996): IGF2 but not H19 shows loss of imprinting in human glioma. Cancer Res 56:5356-5359.
79. Varanasi R, Bardeesy N, Ghahremani M, Petruzzi M-J, Nowak N, Adam MA, Grundy P, Shows TB, Pelletier J (1994): Fine structure analysis of the WT1 gene in sporadic Wilms tumors. Proc Natl Acad Sci USA 91:3554-3558.
80. Vu TH, Hoffman AR (1994): Promoter-specific imprinting of the human insulin-like growth factor-II gene. Nature 371:714-717.
81. Wang-Wuu S, Soukup S, Bove K, Gotwals B, Lampkin B (1990): Chromosome analysis of 31 wilms' tumors. Cancer Res 50:2786-2793.
82. Weksberg R, Shen DR, Fei YL, Song QL, Squire J (1993): Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nature Genet 5:143-150.
83. Wiedemann HR (1964): Complexe malformatif familial avec hernie ombilicale et marcroglossie - un "syndrome nouveau"? J Génét Hum 13:223-232.
84. Wiedemann HR (1983): Tumors and hemihypertrophy associated with Wiedemann-Beckwith syndrome. Eur J Pediatr 141:129.
85. Wilmore HP, White GFJ, Howell RT, Brown KW (1994): Germline and somatic abnormalities of chromosome 7 in Wilms' tumor. Cancer Genet Cytogenet 77:93-98.
86. Zhang Y, Tycko B (1992): Monoallelic expression of the human H19 gene. Nature Genet 1:40-44.